- Home
- VLO vs BDX Comparison
VLO vs BDX Comparison
Compare VLO & BDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VLO
- BDX
- Stock Information
- Founded
- VLO 1980
- BDX 1897
- Country
- VLO United States
- BDX United States
- Employees
- VLO N/A
- BDX N/A
- Industry
- VLO Integrated oil Companies
- BDX Medical/Dental Instruments
- Sector
- VLO Energy
- BDX Health Care
- Exchange
- VLO Nasdaq
- BDX Nasdaq
- Market Cap
- VLO 45.3B
- BDX 49.0B
- IPO Year
- VLO N/A
- BDX 1962
- Fundamental
- Price
- VLO $151.99
- BDX $192.93
- Analyst Decision
- VLO Buy
- BDX Buy
- Analyst Count
- VLO 15
- BDX 9
- Target Price
- VLO $154.07
- BDX $222.75
- AVG Volume (30 Days)
- VLO 2.2M
- BDX 2.4M
- Earning Date
- VLO 10-23-2025
- BDX 08-07-2025
- Dividend Yield
- VLO 2.97%
- BDX 2.16%
- EPS Growth
- VLO N/A
- BDX 12.91
- EPS
- VLO 2.41
- BDX 5.47
- Revenue
- VLO $117,549,000,000.00
- BDX $21,386,000,000.00
- Revenue This Year
- VLO N/A
- BDX $9.40
- Revenue Next Year
- VLO N/A
- BDX $4.76
- P/E Ratio
- VLO $63.00
- BDX $35.28
- Revenue Growth
- VLO N/A
- BDX 7.86
- 52 Week Low
- VLO $99.00
- BDX $163.33
- 52 Week High
- VLO $155.12
- BDX $251.99
- Technical
- Relative Strength Index (RSI)
- VLO 70.98
- BDX 54.32
- Support Level
- VLO $137.88
- BDX $190.74
- Resistance Level
- VLO $147.89
- BDX $195.65
- Average True Range (ATR)
- VLO 3.19
- BDX 2.85
- MACD
- VLO 1.83
- BDX -0.80
- Stochastic Oscillator
- VLO 94.27
- BDX 23.10
About VLO Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 15 refineries, with a total throughput capacity of 3.2 million barrels a day in the US, Canada, and the United Kingdom. Valero also owns 12 ethanol plants with capacity of 1.6 billion gallons a year and holds a 50% stake in Diamond Green Diesel, which can produce 1.2 billion gallons per year of renewable diesel.
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.